| CAS NO: | 1258595-14-0 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 200mg | 电议 |
| 生物活性 | LHC-165 is aTLR7agonist. LHC-165 has potential to used in study of solid tumors[1][2]. | ||||||||||||||||
| IC50& Target[1] |
| ||||||||||||||||
| Clinical Trial | |||||||||||||||||
| 分子量 | 603.55 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C29H32F2N3O7P | ||||||||||||||||
| CAS 号 | 1258595-14-0 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 | -20°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) | ||||||||||||||||
| 溶解性数据 | In Vitro: 1M NaOH : 50 mg/mL(82.84 mM;ultrasonic and adjust pH to 12 with NaOH) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
